These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 627526)

  • 41. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.
    Vuye A
    Arzneimittelforschung; 1981; 31(8):1290-5. PubMed ID: 6457607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cefoxitin, a new semi-synthetic cephamycin (author's transl)].
    Stapley EO; Birnbaum J
    Sem Hop; 1978 Oct 8-15; 54(29-32):975-81. PubMed ID: 216093
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cephamycins, a new family of beta-lactam antibiotics. 3. In vitro studies.
    Miller AK; Celozzi E; Pelak BA; Stapley EO; Hendlin D
    Antimicrob Agents Chemother; 1972 Oct; 2(4):281-6. PubMed ID: 4670501
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In-vitro antibacterial activity of cefotetan.
    Grassi GG; Alesina R; Ferrara A; Peona V
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():45-58. PubMed ID: 6573325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Laboratory and clinical studies of 6059-S in pediatric field (author's transl)].
    Nishimura T; Hiromatsu K; Takashima T; Tabuki K; Takagi M
    Jpn J Antibiot; 1981 May; 34(5):800-16. PubMed ID: 6457177
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cefoxitin, a new semi-synthetic cephamycin: an in-vitro and in-vivo comparison with cephalothin.
    Kosmidis J; Hamilton-Miller JM; Gilchrist JN; Kerry DW; Brumfitt W
    Br Med J; 1973 Dec; 4(5893):653-5. PubMed ID: 4202265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Laboratory and clinical studies of cefmetazole in serious infection by Staphylococcus (author's transl)].
    Motohiro T; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Onoda Y; Kusayanagi T; Tsuboi M; Toubo Y; Yamamoto M; Komatsu R; Tanaka C; Baba Y
    Jpn J Antibiot; 1982 Mar; 35(3):821-34. PubMed ID: 6954289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cefoxitin, a semi-synthetic cephamycin: a microbiological overview.
    Birnbaum J; Stapley EO; Miller AK; Wallick H; Hendlin D; Woodruff HB
    J Antimicrob Chemother; 1978 Jul; 4(B):15-32. PubMed ID: 357379
    [No Abstract]   [Full Text] [Related]  

  • 49. The activity of cefbuperazone, a 7 alpha-methoxy 7 beta acyl ureido cephalosporin.
    Neu HC; Chin NX; Labthavikul P
    Chemioterapia; 1985 Dec; 4(6):415-23. PubMed ID: 3879464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Susceptibility of clinically isolated Haemophilus influenzae to cephamycin antibiotics].
    Deguchi K
    Jpn J Antibiot; 1983 May; 36(5):1103-8. PubMed ID: 6604823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial activity of SK&F 88070, an expanded-spectrum cephalosporin with high and prolonged levels in blood.
    Grappel SF; Phillips L; Dunn GL; Jakas DR; Pitkin D; Actor P
    Antimicrob Agents Chemother; 1984 Jun; 25(6):694-700. PubMed ID: 6742815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula.
    Esposito S; Galante D; Barba D
    Chemioterapia; 1986 Apr; 5(2):101-4. PubMed ID: 3518963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Laboratory and clinical studies on cefoxitin in pediatric field (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Osuga T; Inokuma K
    Jpn J Antibiot; 1981 Mar; 34(3):287-304. PubMed ID: 7289022
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Experimental and clinical studies of cefmetazole in the field of oral surgery].
    Minami Y; Taguchi M; Nanba R; Tsuto H; Yamamoto T; Ueda K; Tsushima T; Morihana T; Nagata K; Nakao K; Shimada K
    Jpn J Antibiot; 1982 May; 35(5):1308-21. PubMed ID: 6957626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of cephamycins in obstetrics and gynecology.
    Sweet RL
    J Reprod Med; 1990 Nov; 35(11 Suppl):1064-9. PubMed ID: 2277374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In-vitro activity of cefotetan and other cephalosporins against multiresistant strains of Enterobacteriaceae.
    Leigh DA; Marriner J
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():103-5. PubMed ID: 6573310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [In vitro activity of cefoxitin compared with the activity of other antibiotics and trimethoprim-sulfamethoxazole (author's transl)].
    Freitag V
    Med Klin; 1978 Mar; 73(12):423-7. PubMed ID: 347234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An update on the in vitro activity of ceftizoxime and other cephalosporin/cephamycin antimicrobial agents against clinically significant anaerobic bacteria.
    Aldridge KE
    Clin Ther; 1990; 12 Suppl C():3-12. PubMed ID: 2202509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cefmetazole (CS-1170): a new cephamycin with activity against gram-negative bacilli and staphylococci.
    Benlloch M; Torres A; Soriano F
    J Antimicrob Chemother; 1982 Oct; 10(4):347-50. PubMed ID: 6958672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.